Suspension of trading on AIM
2nd September 2009
Intercytex Group plc (LSE: ICX) ("Intercytex") today announces temporary suspension of trading of its shares on AIM. As a result of the ongoing divestment process, the Company will not be in a position to release interim financial results before 30 September 2009, and will therefore be suspended from trading until such results are released.
The Company remains in advanced discussions with a number of parties to divest certain business assets, and will continue to update shareholders on both the progress of the strategic review and the potential timing of release of interim financial results.
Enquiries
For more information, contact:
| Intercytex Group plc | |
| Nick Higgins, Chief Executive Officer | Tel: 0161 904 4500 |
| Max Herrmann, Chief Financial Officer | |
| Financial Dynamics | |
| Jonathan Birt | Tel: 0207 269 7205 |
| Piper Jaffray Ltd | |
| Will Carnwath | Tel: 0203 142 8700 |
Intercytex' shares trade on AIM, a market of the London Stock Exchange, under the ticker symbol ICX.L.
Additional information on the Company can be found at www.intercytex.com
Statements contained within this press release may contain forward-looking information or statements with respect to the financial condition, results of operations and business achievements/performance of Intercytex and certain of the plans and objectives of management of Intercytex with respect thereto. By their nature, forward-looking statements involve risks and uncertainties that may cause actual results to vary from those contained in the forward-looking statements. In some cases, you can identify such forward-looking statements by terminology such as 'may', 'will', 'could', 'forecasts', 'expects', 'plans', 'anticipates', 'believes', 'estimates', 'predicts', 'potential', 'continue' or similar expressions. A number of factors, including the satisfactory progress of research and development, could cause Intercytex' actual financial condition, results of operations and business achievements/performance to differ materially from the estimates made or implied in such forward-looking statements and, accordingly, reliance should not be placed on such statements. Forward projections reflect management's best estimates based on information available at the time of issue and are not a guarantee of future performance. Other than as required by applicable law, Intercytex does not undertake any obligation to update or revise any forward-looking information or statements to reflect events or circumstances after the date of this release. The term "Intercytex" refers to Intercytex Group plc and its subsidiary undertakings.